We are live on ! Find out more
CWM

Chemistry Wealth Management Portfolio holdings

AUM $625M
1-Year Est. Return 19.32%
This Fund
S&P 500
This Quarter Est. Return
+8.44%
1 Year Est. Return
+19.32%
3 Year Est. Return
+71.97%
5 Year Est. Return
10 Year Est. Return
AUM
$371M
AUM Growth
+$39.9M
Cap. Flow
+$15.5M
Cap. Flow %
4.19%
Top 10 Hldgs %
53.71%
Holding
167
New
14
Increased
68
Reduced
50
Closed
2

Sector Composition

Rank Sector Weight
1 Financials 27.43%
2 Technology 11.75%
3 Communication Services 9.59%
4 Consumer Discretionary 5.29%
5 Healthcare 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BA icon
151
Boeing
BA
$185B
$220K 0.06%
1,142
-409
-26% -$84K
TXN icon
152
Texas Instruments
TXN
$261B
$218K 0.06%
1,254
+62
+5% +$10.3K
HDV
153
iShares Core High Dividend ETF
HDV
$14.9B
$215K 0.06%
+9,750
New +$205K
GDX icon
154
VanEck Gold Miners ETF
GDX
$27.4B
$212K 0.06%
+6,716
New +$191K
RSG icon
155
Republic Services
RSG
$65.7B
$209K 0.06%
+1,094
New +$194K
DVY icon
156
iShares Select Dividend ETF
DVY
$23.6B
$208K 0.06%
1,685
-25
-1% -$2.93K
ED icon
157
Consolidated Edison
ED
$39.9B
$206K 0.06%
2,274
+10
+0.4% +$897
IVW icon
158
iShares S&P 500 Growth ETF
IVW
$77.6B
$205K 0.06%
+2,427
New +$195K
UNP icon
159
Union Pacific
UNP
$174B
$203K 0.05%
824
B
160
Barrick Mining
B
$73.2B
$190K 0.05%
11,448
-315
-3% -$4.93K
MYN icon
161
BlackRock MuniYield New York Quality Fund
MYN
$377M
$135K 0.04%
12,795
ABEV icon
162
Ambev
ABEV
$46.4B
$90.8K 0.02%
36,618
ANGI icon
163
Angi Inc
ANGI
$196M
$55.1K 0.01%
2,104
+219
+12% +$5.58K
LXRX icon
164
Lexicon Pharmaceuticals
LXRX
$1.1B
$28.8K 0.01%
12,000
AREC icon
165
American Resources Corp
AREC
$293M
$14.1K ﹤0.01%
10,000
LNG icon
166
Cheniere Energy
LNG
$52.9B
-1,180
Closed -$201K
NYT icon
167
New York Times
NYT
$10.2B
-4,567
Closed -$224K

Similar funds

Chemistry Wealth Management's Q1 2024 Portfolio in Review

As of Q1 2024, Chemistry Wealth Management held 167 positions worth $371M, up 12% from $331M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Chemistry Wealth Management deployed $15.5M of net new capital in Q1 2024, opening 14 new positions and adding to 68 existing holdings. Its largest new stake was Cytokinetics: 5,214 shares worth $366K.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Source Capital, an estimated $1.2M trimmed.

  • Chemistry Wealth Management's largest Q1 2024 buy was Cytokinetics: 5,214 shares worth $366K.
  • Chemistry Wealth Management added most to American Express in Q1 2024, an estimated $5.87M increase.
  • Chemistry Wealth Management's biggest Q1 2024 reduction was Source Capital, cutting an estimated $1.2M.
  • Chemistry Wealth Management fully exited New York Times in Q1 2024, selling an estimated $224K.
  • Chemistry Wealth Management's ten largest holdings make up 54% of its $371M portfolio in Q1 2024.
  • Chemistry Wealth Management opened 14 new positions and closed 2 in Q1 2024.
  • Chemistry Wealth Management's portfolio value rose 12% quarter-over-quarter to $371M.

Based on Chemistry Wealth Management's 13F filing for Q1 2024, filed 15 Apr 2024.